Summary | Becton Dickinson and Co, a United States-based
medical technology company, is targeting a 17 percent growth in
sales from China this year to about $600 million, its chairman
said.
medical technology company, is targeting a 17 percent growth in
sales from China this year to about $600 million, its chairman
said.
chinadaily.com.cn | 22 August 2015